TGF-beta receptor signaling has been strongly linked to metastatic disease progression in breast cancer, so downregulation of TGFR-1 in the clone mKO might have been the reason for the non-metastatic phenotype [49, 50]. The gene discussed is TGFBR1; the disease is metastatic neoplasm.